Provided by Tiger Trade Technology Pte. Ltd.

Insmed

125.77
+0.69000.55%
Pre-market: 126.450.6800+0.54%06:51 EDT
Volume:1.12M
Turnover:141.84M
Market Cap:27.47B
PE:-30.76
High:127.20
Open:125.22
Low:124.82
Close:125.08
52wk High:212.75
52wk Low:90.39
Shares:218.38M
Float Shares:216.82M
Volume Ratio:0.67
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0882
EPS(LYR):-6.4200
ROE:-87.22%
ROA:-22.17%
PB:36.26
PE(LYR):-19.59

Loading ...

Insmed shareholders approved 2025 executive pay in advisory vote at annual meeting

Reuters
·
May 16

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-05-15

Reuters
·
May 16

Insmed Is Maintained at Buy by Truist Securities

Dow Jones
·
May 14

Insmed Inc : Truist Securities Cuts Target Price to $185 From $205

THOMSON REUTERS
·
May 14

Insmed price target lowered to $185 from $205 at Truist

TIPRANKS
·
May 14

Stock Track | Insmed Soars 5.78% Intraday on Bullish Analyst Note and Fidelity's New Major Position

Stock Track
·
May 14

Stock Track | Insmed Soars 5.13% as RBC Capital Markets Defends Stock After Post-Earnings Sell-off

Stock Track
·
May 13

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-05-12

Reuters
·
May 13

Stock Track | Insmed Soars 9.80% Intraday as RBC Defends Stock After Post-Earnings Sell-off

Stock Track
·
May 13

Insmed Incorporated (NASDAQ:INSM) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St.
·
May 12

Stock Track | Insmed Soars 5.05% Intraday on Stifel Nicolaus Buy Rating and $200 Price Target

Stock Track
·
May 11

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-05-11

Reuters
·
May 11

Zoetis, Insmed, And HubSpot Are Among Top 10 Large-Cap Losers Last Week (May 4-May 8): Are The Others In Your Portfolio?

Benzinga_recent_news
·
May 10

Insmed earnings selloff a buying opportunity, says H.C. Wainwright

TIPRANKS
·
May 09

Jefferies Remains a Buy on Insmed (INSM)

TIPRANKS
·
May 09

Insmed Stock Sell-off is Overdone as Underlying Metrics Appear Positive, RBC Says

MT Newswires Live
·
May 09

RBC Cuts Price Target on Insmed to $205 From $220, Keeps Outperform Rating

MT Newswires Live
·
May 09

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 08

Insmed Is Maintained at Overweight by Wells Fargo

Dow Jones
·
May 08

Insmed price target lowered to $226 from $230 at Guggenheim

TIPRANKS
·
May 08